Table 2.
Reasons for discontinuation | Number of patients,n (%) |
---|---|
Adverse Events |
40 (18.5) |
No reduction of 2 log viral load at week 12 |
3 (1.4) |
Positive PCR qualitative at week 24 |
5 (2.3) |
Withdrawal of the patients |
3 (1.4) |
Total discontinuation of treatment | 51 (23.6) |